Clin2
NCT06248229Worth exploringRecruiting

Testing Dyanavel XR for fatigue in adults with ADHD

FatigueAttention Deficit Hyperactivity DisorderAttention Deficit Disorder

Part of Mental health clinical trials.

This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old.
  • You have been diagnosed with ADHD and have moderate to severe symptoms (score over 36 on an ADHD rating scale).
  • You have significant fatigue that interferes with your daily life (score over 3 on a fatigue scale).
  • You live in Michigan or within a 50-mile drive of the study site in Michigan.
  • You are not currently taking any stimulant medication for ADHD and have not taken any for at least 3 months.
  • You do not have serious heart disease, a history of seizures, or other unstable medical conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06577779Recruiting· Phase 4
Testing Jornay PM for adult ADHD symptoms into the evening

This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.

New York, New York
NCT07759154Not yet recruiting· Phase 3
A study of centanafadine for adults with ADHD and emotional symptoms

This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.

NCT07745010Not yet recruiting
Study of wellness products for fatigue relief

This trial tests whether a wellness product can reduce fatigue and improve related health issues in adults over 40. Participants will take the product without knowing if they receive the active ingredient or a placebo, and outcomes are measured through surveys.

Del Mar, California
NCT07044609Not yet recruiting· Phase 4
Study of Onyda XR for ADHD and ODD in children

This trial tests a new extended-release medication called Onyda XR (clonidine) in children aged 6 to 12 who have both ADHD and Oppositional Defiant Disorder. The goal is to see if it helps with symptoms like inattention, hyperactivity, and defiant behavior, and if it is safe.

NCT05880342Recruiting· Phase 3
Study how the brain affects fatigue after exercise

This trial studies how your brain responds when you feel mentally and physically tired, using trained healthy volunteers. It may help researchers understand fatigue better, which could guide future treatments for people who struggle with fatigue.

Brussels, Brussels Capital
NCT07653724Not yet recruiting
Study on health products for fatigue and wellness

This trial tests if certain health products can help improve fatigue and related health issues. Participants will take either the active product or a placebo, without knowing which they are getting, to see if there is a real benefit.

Del Mar, California

Hear when a new Fatigue trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.